2025-02-01 2026-01-31 2026-01-31 false 01395693 Elancray Limited 2026-04-27 41100 false iso4217:GBP xbrli:pure 01395693 2025-01-31 01395693 2026-01-31 01395693 2025-02-01 2026-01-31 01395693 2024-01-31 01395693 2025-01-31 01395693 2024-02-01 2025-01-31 01395693 bus:SmallEntities 2025-02-01 2026-01-31 01395693 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 01395693 bus:AbridgedAccounts 2025-02-01 2026-01-31 01395693 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 01395693 core:WithinOneYear 2026-01-31 01395693 core:AfterOneYear 2026-01-31 01395693 core:WithinOneYear 2025-01-31 01395693 core:AfterOneYear 2025-01-31 01395693 core:ShareCapital 2026-01-31 01395693 core:SharePremium 2026-01-31 01395693 core:RevaluationReserve 2026-01-31 01395693 core:OtherReservesSubtotal 2026-01-31 01395693 core:RetainedEarningsAccumulatedLosses 2026-01-31 01395693 core:ShareCapital 2025-01-31 01395693 core:SharePremium 2025-01-31 01395693 core:RevaluationReserve 2025-01-31 01395693 core:OtherReservesSubtotal 2025-01-31 01395693 core:RetainedEarningsAccumulatedLosses 2025-01-31 01395693 core:LandBuildings 2026-01-31 01395693 core:PlantMachinery 2026-01-31 01395693 core:Vehicles 2026-01-31 01395693 core:FurnitureFittings 2026-01-31 01395693 core:OfficeEquipment 2026-01-31 01395693 core:NetGoodwill 2026-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 01395693 core:ListedExchangeTraded 2026-01-31 01395693 core:UnlistedNon-exchangeTraded 2026-01-31 01395693 core:LandBuildings 2025-01-31 01395693 core:PlantMachinery 2025-01-31 01395693 core:Vehicles 2025-01-31 01395693 core:FurnitureFittings 2025-01-31 01395693 core:OfficeEquipment 2025-01-31 01395693 core:NetGoodwill 2025-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2025-01-31 01395693 core:ListedExchangeTraded 2025-01-31 01395693 core:UnlistedNon-exchangeTraded 2025-01-31 01395693 core:LandBuildings 2025-02-01 2026-01-31 01395693 core:PlantMachinery 2025-02-01 2026-01-31 01395693 core:Vehicles 2025-02-01 2026-01-31 01395693 core:FurnitureFittings 2025-02-01 2026-01-31 01395693 core:OfficeEquipment 2025-02-01 2026-01-31 01395693 core:NetGoodwill 2025-02-01 2026-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2025-02-01 2026-01-31 01395693 core:ListedExchangeTraded 2025-02-01 2026-01-31 01395693 core:UnlistedNon-exchangeTraded 2025-02-01 2026-01-31 01395693 core:MoreThanFiveYears 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments 2026-01-31 01395693 core:Non-currentFinancialInstruments 2025-01-31 01395693 dpl:CostSales 2025-02-01 2026-01-31 01395693 dpl:DistributionCosts 2025-02-01 2026-01-31 01395693 core:LandBuildings 2025-02-01 2026-01-31 01395693 core:PlantMachinery 2025-02-01 2026-01-31 01395693 core:Vehicles 2025-02-01 2026-01-31 01395693 core:FurnitureFittings 2025-02-01 2026-01-31 01395693 core:OfficeEquipment 2025-02-01 2026-01-31 01395693 dpl:AdministrativeExpenses 2025-02-01 2026-01-31 01395693 core:NetGoodwill 2025-02-01 2026-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2025-02-01 2026-01-31 01395693 dpl:GroupUndertakings 2025-02-01 2026-01-31 01395693 dpl:ParticipatingInterests 2025-02-01 2026-01-31 01395693 dpl:GroupUndertakings core:ListedExchangeTraded 2025-02-01 2026-01-31 01395693 core:ListedExchangeTraded 2025-02-01 2026-01-31 01395693 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-02-01 2026-01-31 01395693 core:UnlistedNon-exchangeTraded 2025-02-01 2026-01-31 01395693 dpl:CostSales 2024-02-01 2025-01-31 01395693 dpl:DistributionCosts 2024-02-01 2025-01-31 01395693 core:LandBuildings 2024-02-01 2025-01-31 01395693 core:PlantMachinery 2024-02-01 2025-01-31 01395693 core:Vehicles 2024-02-01 2025-01-31 01395693 core:FurnitureFittings 2024-02-01 2025-01-31 01395693 core:OfficeEquipment 2024-02-01 2025-01-31 01395693 dpl:AdministrativeExpenses 2024-02-01 2025-01-31 01395693 core:NetGoodwill 2024-02-01 2025-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2024-02-01 2025-01-31 01395693 dpl:GroupUndertakings 2024-02-01 2025-01-31 01395693 dpl:ParticipatingInterests 2024-02-01 2025-01-31 01395693 dpl:GroupUndertakings core:ListedExchangeTraded 2024-02-01 2025-01-31 01395693 core:ListedExchangeTraded 2024-02-01 2025-01-31 01395693 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-02-01 2025-01-31 01395693 core:UnlistedNon-exchangeTraded 2024-02-01 2025-01-31 01395693 core:NetGoodwill 2026-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 01395693 core:LandBuildings 2026-01-31 01395693 core:PlantMachinery 2026-01-31 01395693 core:Vehicles 2026-01-31 01395693 core:FurnitureFittings 2026-01-31 01395693 core:OfficeEquipment 2026-01-31 01395693 core:AfterOneYear 2026-01-31 01395693 core:WithinOneYear 2026-01-31 01395693 core:ListedExchangeTraded 2026-01-31 01395693 core:UnlistedNon-exchangeTraded 2026-01-31 01395693 core:ShareCapital 2026-01-31 01395693 core:SharePremium 2026-01-31 01395693 core:RevaluationReserve 2026-01-31 01395693 core:OtherReservesSubtotal 2026-01-31 01395693 core:RetainedEarningsAccumulatedLosses 2026-01-31 01395693 core:NetGoodwill 2025-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2025-01-31 01395693 core:LandBuildings 2025-01-31 01395693 core:PlantMachinery 2025-01-31 01395693 core:Vehicles 2025-01-31 01395693 core:FurnitureFittings 2025-01-31 01395693 core:OfficeEquipment 2025-01-31 01395693 core:AfterOneYear 2025-01-31 01395693 core:WithinOneYear 2025-01-31 01395693 core:ListedExchangeTraded 2025-01-31 01395693 core:UnlistedNon-exchangeTraded 2025-01-31 01395693 core:ShareCapital 2025-01-31 01395693 core:SharePremium 2025-01-31 01395693 core:RevaluationReserve 2025-01-31 01395693 core:OtherReservesSubtotal 2025-01-31 01395693 core:RetainedEarningsAccumulatedLosses 2025-01-31 01395693 core:NetGoodwill 2024-01-31 01395693 core:IntangibleAssetsOtherThanGoodwill 2024-01-31 01395693 core:LandBuildings 2024-01-31 01395693 core:PlantMachinery 2024-01-31 01395693 core:Vehicles 2024-01-31 01395693 core:FurnitureFittings 2024-01-31 01395693 core:OfficeEquipment 2024-01-31 01395693 core:AfterOneYear 2024-01-31 01395693 core:WithinOneYear 2024-01-31 01395693 core:ListedExchangeTraded 2024-01-31 01395693 core:UnlistedNon-exchangeTraded 2024-01-31 01395693 core:ShareCapital 2024-01-31 01395693 core:SharePremium 2024-01-31 01395693 core:RevaluationReserve 2024-01-31 01395693 core:OtherReservesSubtotal 2024-01-31 01395693 core:RetainedEarningsAccumulatedLosses 2024-01-31 01395693 core:AfterOneYear 2025-02-01 2026-01-31 01395693 core:WithinOneYear 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:CostValuation 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 01395693 core:Non-currentFinancialInstruments core:CostValuation 2026-01-31 01395693 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-01-31 01395693 core:Non-currentFinancialInstruments core:CostValuation 2025-01-31 01395693 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-31 01395693 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-31 01395693 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-31 01395693 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-31 01395693 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-31 01395693 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-31 01395693 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-31 01395693 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-31 01395693 bus:Director1 2025-02-01 2026-01-31 01395693 bus:Director2 2025-02-01 2026-01-31

Elancray Limited

Registered Number
01395693
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

Elancray Limited
Company Information
for the year from 1 February 2025 to 31 January 2026

Directors | George, Rosalind Mary
| Thorne, Alethea Gaye Kendall

Registered Address | 107 North Street
| Martock
| TA12 6EJ

Registered Number | 01395693 (England and Wales)

Elancray Limited
Balance Sheet as at
31 January 2026

| Notes | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Investments | 3 |  |  | 2,000 |  |  |  | 2,000
|  |  |  | 2,000 |  |  |  | 2,000
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 4,470 |  |  |  | 3,510 |  |
Cash at bank and on hand |  | 130 |  |  |  | 872 |  |
|  | 4,600 |  |  |  | 4,382 |  |
Creditors amounts falling due within one year | 5 | (3,091) |  |  |  | (3,037) |  |
Net current assets (liabilities) |  |  |  | 1,509 |  |  |  | 1,345
Total assets less current liabilities |  |  |  | 3,509 |  |  |  | 3,345
Net assets |  |  |  | 3,509 |  |  |  | 3,345
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 3,409 |  |  |  | 3,245
Shareholders' funds |  |  |  | 3,509 |  |  |  | 3,345

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
- The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 27 April 2026, and are signed on its behalf by:
George, Rosalind Mary Director
Thorne, Alethea Gaye Kendall Director Registered Company No. 01395693

Elancray Limited
Notes to the Financial Statements
for the year ended 31 January 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Investments
--- | ---
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

2. | Average number of employees
--- | ---

|  | 2026 |  | 2025
| Average number of employees during the year | 0 |  | 0

3. | Fixed asset investments
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 February 25 | 2,000
| At 31 January 26 | 2,000
| Net book value
| At 31 January 26 | 2,000
| At 31 January 25 | 2,000

4. | Debtors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 4,470 |  | 3,510
| Total | 4,470 |  | 3,510

| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

5. | Creditors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Other creditors | 1,915 |  | 1,915
| Accrued liabilities and deferred income | 1,176 |  | 1,122
| Total | 3,091 |  | 3,037

| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.